Boston – October 28, 2026 – Cooley advised Formation Bio, an AI-native pharmaceutical company, on the formation and fundraising of its $600 million Formation Bio Drug Development Accelerator Fund.

The fund pairs dedicated capital with Formation Bio’s drug development capabilities, team and AI platform to acquire and advance promising drug programs through clinical development. The fund will seek to invest in individual drug programs, license them into newly formed, asset-centric companies and advance them through key clinical milestones.

Lawyers Matthew Smith and Chris Bates led the Cooley team advising Formation Bio, with support from Stacey Song, Aalok Virmani, Ifunanya Okobi-Harris, Meredith Ashlock and Anya Castillo.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.